Testing methods for MGMT promoter methylation

Neuro-Oncology: The Podcast - A podcast by Neuro-Oncology - Fridays

Dr. Iyad Alnahhas interviews Dr. Kathreena Kurian about her and her team's recent manuscript entitled: "MGMT promoter methylation testing to predict overall survival in people with glioblastoma treated with temozolomide: a comprehensive meta-analysis based on a Cochrane Review", published online in Neuro-Oncology in April 2021.

Visit the podcast's native language site